Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
1390 Results for "
antigen receptor
" in MedChemExpress (MCE) Product Catalog:
Products (1390)
1390 Results for "antigen receptor" in MCE Product Catalog:
36
Research Areas:
MK-571 (L-660711) is an orally active, potent and selective competitive leukotriene D4 (LTD4) receptor antagonist, with Ki values of 0.22 and 2.1 nM in guinea pig and human lung membranes, respectively. MK-571 is also a MRP4 and ABCC1 (MRP1) inhibitor. MK-571 inhibits constitutive and antigen-stimulated S1P (sphingosine-1-phosphate) release .
36
Research Areas:
MK-571 (L-660711) sodium is an orally active, potent and selective competitive leukotriene D4 (LTD4) receptor antagonist, with Ki values of 0.22 and 2.1 nM in guinea pig and human lung membranes, respectively. MK-571 sodium is also a inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1). MK-571 sodium inhibits constitutive and antigen-stimulated S1P (sphingosine-1-phosphate) release .
5
5
5 Cited Publications
Synonyms: P505-15; PRT-2607; BIIB-057
Research Areas:
PRT062607 (P505-15; PRT-2607) is an orally active ATP-competitive Syk inhibitor with an IC50 value of 1 nM, and exhibits at least 80-fold selectivity over other kinases. PRT062607 blocks B cell antigen receptor-mediated activation, Fcε receptor 1-mediated basophil degranulation and microglial phagocytosis, and induces caspase-dependent apoptosis and microglial death. PRT062607 inhibits tumor growth and peripheral nerve injury-induced mechanical allodynia, and prevents neuronal loss. PRT062607 can be used in research related to rheumatoid arthritis, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, neurodegenerative diseases and neuropathic pain .
4
4 Cited Publications
Synonyms: α-GalCer; KRN7000
Research Areas:
α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor) .
4
4
4 Cited Publications
Cat. No.: HY-P70309
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LGALS3; MAC-2; Prev. LGALS2; MAC2; GALIG; Galactoside-Binding Protein; Epididymis Secretory Sperm Binding Protein; MAC-2 antigen; Advanced Glycation End-Product receptor 3; Mac-2 antigen; Lectin, Galactoside-Binding, Soluble, 3; Galectin; Carbohydrate-Bin
4
4 Cited Publications
Cat. No.: HY-P77699
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL15RA; IL-15 receptor Subunit Alpha; Interleukin 15 receptor Subunit Alpha; IL15RA Protein; Interleukin-15 receptor Subunit Alpha; CD215 antigen; IL-15RA; IL-15R-Alpha; CD215; Il15ra; Interleukin 15 receptor, Alpha; IL15; Interleukin-15; Interleukin 15;
3
Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Orelabrutinib prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the growth of malignant B-cells that overexpress BTK .
3
3 Cited Publications
Cat. No.: HY-P78558
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL15RA; IL-15 receptor Subunit Alpha; Interleukin 15 receptor Subunit Alpha; IL15RA Protein; Interleukin-15 receptor Subunit Alpha; CD215 antigen; IL-15RA; IL-15R-Alpha; CD215; Il15ra; Interleukin 15 receptor, Alpha; IL15; Interleukin-15; Interleukin 15;
3
3 Cited Publications
Cat. No.: HY-P702520
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LRP1; Apolipoprotein E receptor; Prev. A2MR; TbetaR-V/LRP-1/IGFBP-3 receptor; Prev. APR; Type V Tgf-Beta receptor; APOER; Alternative Protein LRP1; Alpha-2-Macroglobulin receptor; CD91 antigen; IGFBP3R1; LRP1 Protein; IGFBP-3R; IGFBP3R; LRP1A; TGFBR5; CD9
3
3 Cited Publications
Cat. No.: HY-P70147
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: NRP1; Transmembrane receptor; Neuropilin 1; CD304 antigen; VEGF165R; DKFZp686M1967; NRP; Neuropilin; Neuropilin-1; BDCA4; CD304; NP1; Vascular Endothelial Cell Growth Factor 165 receptor
3
3
2
2 Cited Publications
Cat. No.: HY-P81177
Synonyms: Scavenger receptor cysteine-rich type 1 protein M130; CD 163; CD163 antigen; CD163 molecule; Hemoglobin Scavenger receptor; M130; M130 antigen precursor; Macrophage associated antigen; MM130; C163A_HUMAN.
2
2 Cited Publications
Cat. No.: HY-P81643
Synonyms: KDR; FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309
2
2 Cited Publications
Cat. No.: HY-P78723
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IGF1R; IGF-I receptor; Insulin Like Growth Factor 1 receptor; MGC18216; Insulin-Like Growth Factor 1 receptor; Insulin-Like Growth Factor I receptor; JTK13; receptor Protein-Tyrosine Kinase; CD221; Tyrosine-Protein Kinase receptor; IGFIR; CD221 antigen; I
2
2 Cited Publications
Cat. No.: HY-P71963
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IL17RA; Interleukin-17 receptor A; Prev. IL17R; Interleukin 17 receptor; IL-17RA; CD217 antigen; CDw217; CANDF5; HIL-17R; IMD51; CD217; Interleukin 17 receptor A; IL-17 receptor A
2
2 Cited Publications
Cat. No.: HY-P81214
Synonyms: Mannose receptor; C-type lectin domain family 13 member D; CD 206; CD206; CD206 antigen; CLEC13D; CLEC13DL; Macrophage mannose receptor; Mannose receptor C type 1; MMR; MRC 1; MRC-1; MRC1_HUMAN; Macrophage mannose receptor 1; MRC1L1; C-type lectin domain family 13 member D-like; Macrophage mannose receptor 1-like protein 1.
2
2 Cited Publications
Cat. No.: HY-P70004
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CD36; Leukocyte Differentiation antigen CD36; CD36 Molecule (CD36 Blood Group); Thrombospondin receptor; Platelet Glycoprotein 4; CD36 antigen; GPIIIB; PAS-4; GPIV; CD36 Molecule (CD36 Blood Group) Transcript; GP3B; Scavenger receptor Class B, Member 3; F
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
